Trial intelligence / Profile preview

Antenatal Betamethasone Effect on Fetal Pulmonary Artery Flow

NCT02978976Phase 4Unknown

Sponsor
Kasr Al Ainy Hospital
Start
Jan 2017
Primary completion
Apr 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of betamethasone in respiratory distress syndrome (RDS) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Mean Doppler parameters of the fetal pulmonary artery at 1 week. Status: unknown.

02

Drugs

betamethasone
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NCT02978976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02978976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call